High-Risk de Novo Multiple Myeloma
1 clinical trials · Condition
◉ Watch High-Risk de Novo Multiple Myeloma
| Record | Firm | Date |
|---|---|---|
| Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma (NCT05849610) | PETHEMA Foundation | 2023-09-21 |
Track High-Risk de Novo Multiple Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.